Nesvacumab Biosimilar - Research Grade, Low Endotoxin

Nesvacumab Biosimilar - Research Grade, Low Endotoxin

Catalog Number:
A001437394ICH
Mfr. No.:
ICH5010
Price:
$560
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Specificity: Detects human Ang-2. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Nesvacumab.
          Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
          Isotype Control: Bulk Human IgG1 Isotype Control (IB1) [ICH2254]
          Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method

          Please contact us at for specific academic pricing.

          Background

          RUO nesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer. It targets the protein angiopoietin 2. As of May 2017, it is in Phase II clinical trials for the treatment of diabetic macular edema.

      • Properties
        • Isotype
          IgG1
          Reactivity
          human
          Purification
          >95% by SDS-PAGE
          Formulation
          Sterile, preservative-free, solution in PBS. BSA and Azide free.
          Storage
          This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
          Molecular Weight
          5mg/ml
          Antigen
          (Gene ID:ANGPT2, ANG2)

          * Products are for research use only. Not for use in diagnostic or therapeutic procedures.

      • Applications
        • Application
          Functional Assays

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.